Skip to main content
padlock icon - secure page this page is secure
Current Radiopharmaceuticals publishes original research articles, letters, reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations. The scope of the journal covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 1, 2016

Articles

Free Content Graphical Abstracts:
pp. i-iii(3)

Favourites:
ADD

Free Content Meet Our Editorial Board Member:
pp. 1-1(1)
Author: M.R. Pillai, Ambikalmajan

Favourites:
ADD

Free Content Editorial Review 2015:
pp. 2-5(4)
Authors: L. Kitson, Sean; Mansi, Luigi

Favourites:
ADD
Favourites:
ADD

Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT
pp. 8-18(11)
Authors: A.P. Breeman, Wouter; Sze Chan, Ho; M.S. de Zanger, Rory; K. Konijnenberg, Mark; de Blois, Erik

Favourites:
ADD

Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience
pp. 19-32(14)
Authors: Carollo, Angela; Papi, Stefano; Chinol, Marco

Favourites:
ADD

Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy
pp. 33-43(11)
Authors: Stott Reynolds, Tamila; P. Bandari, Rajendra; Jiang, Zongrun; J. Smith, Charles

Favourites:
ADD

Radioimmunotherapy of Metastatic Prostate Cancer with ;177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
pp. 44-53(10)
Authors: Vallabhajosula, Shankar; Nikolopoulou, Anastasia; S. Jhanwar, Yuliya; Kaur, Gurveen; T. Tagawa, Scott; M. Nanus, David; H. Bander, Neil; J. Goldsmith, Stanley

Favourites:
ADD

Development and biological studies of ;177Lu-DOTA-rituximab for the treatment of Non-Hodgkin’s lymphoma
pp. 54-63(10)
Authors: V.F. Massicano, Adriana; B. Pujatti, Priscilla; F. Alcarde, Lais; F. Suzuki, Miriam; J. Spencer, Patrick; B. Araújo, Elaine

Favourites:
ADD

Evaluation of ;177Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy
pp. 64-70(7)
Authors: Chakraborty, Sudipta; Balogh, Lajos; Das, Tapas; Polyák, András; Andócs, Gábor; Máthé, Domokos; Király, Réka; Thuróczy, Julianna; R. Chaudhari, Pradip; A. Jánoki, Gyozo; Jánoki, Gergely; Banerjee, Sharmila; Pillai, M. R.A.

Favourites:
ADD

Pharmacokinetic, Dosimetry and Toxicity Study of ;177Lu-EDTMP in Patients: Phase 0/I study
pp. 71-84(14)
Authors: Bal, Chandrasekhar; Arora, Geetanjali; Kumar, Praveen; Damle, Nishikant; Das, Tapas; Chakraborty, Sudipta; Banerjee, Sharmila; Venkatesh, Meera; J. Zaknun, John; R.A. Pillai, M.

Favourites:
ADD

177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
pp. 85-93(9)
Authors: Balter, Henia; Victoria, Trindade; Mariella, Terán; Javier, Gaudiano; Rodolfo, Ferrando; Andrea, Paolino; Graciela, Rodriguez; Juan, Hermida; Eugenia, De M.; Patricia, Oliver

Favourites:
ADD

Theranostic Applications of Lutetium-177 in Radionuclide Therapy
pp. 94-101(8)
Authors: Das, Tapas; Banerjee, Sharmila

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more